Results 21 to 30 of about 51,717 (226)

Pleuropulmonary aspergillosis in an immunocompetent patient presenting as pleural-based peripheral lung mass: A sporadic occurrence

Journal of Association of Pulmonologist of Tamil Nadu, 2021
The importance of knowledge about pulmonary aspergillosis has increased immensely in the era of COVID-19 as a significant number of post-COVID patients develop lung infection with aspergillosis, an entity called COVID-associated pulmonary aspergillosis ...
P Amal Johnson, R Narasimhan, Ajay Narasimhan   +2 more
doaj   +1 more source

Invasive aspergillosis [PDF]

Medical Mycology, 2000
Acute invasive aspergillosis (IA) is a devastating disease. Early diagnosis allowing an early treatment may improve the prognosis. However, this goal remains difficult to achieve. When diagnosis is confirmed it is often already too late. Galactomannan antigen detection and DNA detection are under clinical evaluation to improve early diagnosis and ...
Verweij, P.E., Figueroa, M., Burik, J. van, Holdom, M.D., Dei-Cas, E., Gomez, B.L., Mendes-Giannini, M.J.   +6 more
openaire   +4 more sources

Pulmonary Aspergillosis [PDF]

Seminars in Respiratory and Critical Care Medicine, 2008
As the population of patients with prolonged neutropenia, those receiving hematopoietic stem cell transplantation or lung transplantation, or those with human immunodeficiency virus or acquired immunodeficiency syndrome continues to increase, the rising incidence of pulmonary aspergillosis is unlikely to diminish.
George R, Thompson, Thomas F, Patterson
openaire   +2 more sources

Late-onset isavuconazole-induced liver injury

Medical Mycology Case Reports, 2018
Antifungal agents account for approximately 3% of Drug-Induced Liver Injury (DILI) cases. Isavuconazole is a novel triazole, and experience with long-term use of it is lacking.
Felix Bongomin, Isabel Rodriguez-Goncer, Carol Lorden, Akaninyene Otu, Rohit Bazaz   +4 more
doaj   +1 more source

Successful long-term terbinafine therapy in an asthmatic patient with Aspergillus sensitization and bronchiectasis

Medical Mycology Case Reports, 2017
Severe asthma with fungal sensitization (SAFS) is estimated to affect ~25% of patients with poorly controlled asthma. Tri-azole therapy is effective in only 60–80% and side effects are common.
Isabel Rodriguez-Goncer, Rob Niven, David W. Denning   +2 more
doaj   +1 more source

Metagenomic next-generation sequencing for the diagnosis of pulmonary aspergillosis in non-neutropenic patients: a retrospective study

Frontiers in Cellular and Infection Microbiology, 2022
This study aimed to obtain further in-depth information on the value of metagenomic next-generation sequencing (mNGS) for diagnosing pulmonary aspergillosis in non-neutropenic patients.
Shujun Bao, Huihui Song, Yang Chen, Caiming Zhong, Hao Tang   +4 more
doaj   +1 more source

Nebulised N-Acetylcysteine for Unresponsive Bronchial Obstruction in Allergic Brochopulmonary Aspergillosis: A Case Series and Review of the Literature

Journal of Fungi, 2018
Many chronic lung diseases are characterized by the hypersecretion of mucus. In these conditions, the administration of mucoactive agents is often indicated as adjuvant therapy. N-acetylcysteine (NAC) is a typical example of a mucolytic agent.
Akaninyene Otu, Philip Langridge, David W. Denning   +2 more
doaj   +1 more source

Possible environmental origin of resistance of Aspergillus fumigatus to medical triazoles. [PDF]

, 2009
Contains fulltext : 81920.pdf (Publisher’s version ) (Open Access)We reported the emergence of resistance to medical triazoles of Aspergillus fumigatus isolates from patients with invasive aspergillosis.
Melchers, W.J.G., A. J. M. M. Rijs, Veld, R., G. H. J. Kema, Verweij, P.E., Snelders, E., Kema, G.H.J., W. J. G. Melchers, Kema, G.H., E. Snelders, Rijs, A., Rijs, A.J.M.M., Huis In 't Veld, R.A., P. E. Verweij, R. A. G. Huis in 't Veld   +14 more
core   +1 more source

Immunodiagnosis of aspergillosis [PDF]

Clinical Microbiology Reviews, 1991
Aspergillus species are ubiquitous fungi and have been implicated as the causative agents of a variety of lung disorders in humans. These disorders include allergic, saprophytic, and systemic manifestations. The allergic disorders mainly affect atopic persons, and invasive or systemic diseases affect immunosuppressed individuals.
V P, Kurup, A, Kumar
openaire   +2 more sources

Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin - review of the literature

European Journal of Medical Research, 2011
Major progress for the management of invasive aspergillosis has come from the introduction of new antifungals since the late 1990s. Although mortality of invasive aspergillosis remains as high as 30-50%.
Karthaus M
doaj   +1 more source